As a pioneer in the field of exosome therapeutics Evox has established an impressive foundational portfolio of intellectual property. Evox prides itself on having created a comprehensive IP portfolio encompassing all key aspects of exosome-based drug delivery technology.
Evox’s IP Portfolio:
Cargo loading technology
Cargo loading technology
RNA, gene-editing and protein replacement cargos
Manufacturing and purification methods
Manufacturing and purification methods
Cellular engineering technology, upstream optimization and downstream processing, analytics and quality control
Pharmacokinetics & pharmacodynamics
Pharmacokinetics & pharmacodynamics
Half-life extension
Targeting and release technologies
Targeting and release technologies
Bioactive release and organ targeting
The Evox IP portfolio includes granted and pending applications in all major pharmaceutical markets, including USA, Europe, Japan, China and Korea as well as many other jurisdictions. In addition, trade-secrets, know-how, copyrights and trademarks complete a broad and deep protection for the company’s intellectual assets.